-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $320.00/Share From $536.00 by Goldman Sachs

Dow Jones·10/30/2026 17:35:00

Please log in to view news